CAMBRIDGE, MA (March 15, 2013) – MassBio members today elected three new life sciences executives to the organization’s Board of Directors at the 2013 MassBio Annual Meeting.

Joining the board this year are Lisa Olson, Divisional Vice President of Immunology Research & ABC Site Head at AbbVie, Alice Lin Pomponio, Leader of Americas Science Relations at AstraZeneca, and Debasish Roychowdhury, Head of Oncology at Sanofi.

“As an organization that aims to reflect the depth and breadth of our membership, we are thrilled to add three such prestigious names to our Board of Directors,” said MassBio President & CEO Robert K. Coughlin. “Lisa represents the new iteration of a long-time industry powerhouse, Alice brings a pure-play global biopharma R&D perspective, and Debasish represents one of our newest global players making a home in Massachusetts. We thank them all for their commitment to the industry here.”

Also joining the board is Renee Connolly, Vice President of US Communications for EMD Serono, who fills a seat on the board reserved for the Chair of the Board of the MassBioEd Foundation.

The 2013-2014 members of the MassBio Executive Committee are:

Chair               Geoff MacKay, Organogenesis Inc.

Vice Chair       Glenn Batchelder, Civitas Therapeutics

Treasurer        Michael O'Hara, Deloitte

Clerk               Abbie Celniker, Eleven Biotherapeutics

Past Chair       Geoffrey Cox, Red Sky Partners

Counsel           Lawrence Wittenberg, Goodwin Proctor

The 2013-2014 members of the MassBio Board of Directors are:

Caren Arnstein, Genzyme

Mark Bamforth, Gallus Biopharmaceuticals

Margaret Chu-Moyer, Amgen

Jeffrey Elton, Accenture

Scott Gillis, Onsite Therapeutics

Steven Gilman, Cubist Pharmaceuticals

Jose Carlos Gutierrez-Ramos, Pfizer

James Hoyes, EMD Serono

Edwin Kania, Flagship Ventures

Laurie Bartlett Keating, Millennium: The Takeda Oncology Company

Mark Leuchtenberger

David Lucchino, Semprus BioSciences

Lisa Olson, AbbVie

Deanna Petersen, Shire Pharmaceuticals

Alice Lin Pomponio, AstraZeneca

Steven Richter, Microtest Laboratories

Debasish Roychowdhury, Sanofi Oncology

Amit Sachdev, Vertex Pharmaceuticals

Frank Thomas, AMAG Pharmaceuticals

Kathleen Tregoning, Biogen Idec

Charles Wilson, Novartis

Lawrence Wittenberg, Goodwin Procter

Bill McDermott, McDermott, Quilty & Miller

Robert Gottlieb, RMG Associates